Biotech Stock Skyrockets 30% After Announcing Strategic Partnership

Absci's Stock Skyrockets Following Strategic R&D Partnership with PrecisionLife.

The world of biotechnology is buzzing with the recent news that Absci Corporation (NASDAQ: ABSI) shares have soared by a staggering 29%, closing at $4.31 on the day. This leap in value comes hot on the heels of last week's announcement of a strategic R&D partnership between Absci and PrecisionLife, a pioneering AI-driven drug discovery company.

This part…